SUBSCRIBE
SUBSCRIBE
News   Deals

Pfizer Inc. (JOBS) Eyes Deal with Israel’s Protalix Biotherapeutics

November 2, 2009 | 
1 min read
Bookmark and Share

Reuters -- Pfizer, the world's largest drugmaker, is considering a cooperation deal with Protalix Biotherapeutics and may even try to buy the Israeli company, TheMarker financial newspaper said on Monday.
Mergers & acquisitions
Pfizer
MORE ON THIS TOPIC
Handshake in retro collage style. Hands with halftone effect make a deal, a hand comes out of a laptop, online deals. Vector modern illustration.
Immunology and inflammation
Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026
January 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides
January 29, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
A contemporary art collage depicting a giant ear listening to a message bubble while covering it with a hand. The concept of taking in a useful experience or overhearing a new idea.
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
January 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Pictured: Boehringer Ingelheim's office in California
Inflammatory bowel disease
Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere
January 27, 2026
 · 
2 min read
 · 
Tristan Manalac